IG 278 (Topiramate 25 mg)
Pill with imprint IG 278 is White, Round and has been identified as Topiramate 25 mg. It is supplied by InvaGen Pharmaceuticals, Inc..
Topiramate is used in the treatment of epilepsy; lennox-gastaut syndrome; seizure prevention; migraine prevention; seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for IG 278
- IG 278
- 25 mg
- 6.00 mm
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- InvaGen Pharmaceuticals, Inc.
- Inactive Ingredients
lactose monohydrate, microcrystalline cellulose, corn starch, sodium starch glycolate type A potato, magnesium stearate, silicon dioxide, hypromellose 2910 (3 mPa.s), hypromellose 2910 (6 mPa.s), polyethylene glycol 400, polysorbate 80
Note: Inactive ingredients may vary.
Labelers / Repackagers
|NDC Code||Labeler / Repackager|
|31722-0278||Camber Pharmaceuticals, Inc.|
|60429-0769||Golden State Medical Supply (repackager)|
Related Images for "IG 278"
More about topiramate
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 1109 Reviews
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- FDA Alerts (3)
- Topiramate (Advanced Reading)
- Topiramate Extended-Release Capsules
- Topiramate Extended-Release Sprinkle Capsules
- Topiramate Tablets
- Topiramate Sprinkle Capsules
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.